Inflammatory versus anti-inflammatory profiles in major depressive disorders-the role of IL-17, IL-21, IL-23, IL-35 and Foxp3
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Background: The authors of this research study intended to verify whether there are any changes in gene expression in depressed patients without coexisting inflammatory diseases for selected immune-inflammatory factors that are particularly important in autoimmune disease pathogenesis (IL-17, IL-21, IL-23, IL-35, Foxp3). Methods: The study was carried out on a group of 190 patients with depression and 100 healthy volunteers. The severity of depressive symptoms was assessed using the Hamilton Depression Scale. RT-PCR was used to evaluate mRNA expression and ELISA was used to measure protein expression of these genes. Results: The level of gene expression for IL-17, IL-21, IL-23, and IL-35 was substantially higher in the group of patients with depression compared to the control group. The mean mRNA expression of Foxp3 was considerably reduced in patients suffering from depressive disorders. There was a statistically significant correlation between the number of hospitalizations and the expression of specific inflammatory factors. Conclusions: Expression of specific inflammatory genes may be a factor in the etiopathogenesis of depressive disorders. The duration of the disease seems to be more important for the expression of the genes in question than the severity of depression. These cytokines may affect the metabolism of neurotransmitters and neuroendocrine functions in the brain as well as be a marker and a new potential therapeutic target for recurrent depressive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the immune and inflammatory systems may be crucial contributors to the onset and progression of this life-threatening illness (10,11).”
From Analysis of complete blood count and derived inflammatory indicators for bipolar disorder patients with different states (2023) · doi:10.3389/fpsyt.2023.1219151 · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · cited 1×
“The Ct comparative method was used by the authors to calculate miRNA relative expression of the analyzed genes [16].”
MethodIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 3×
“Additionally, IL-23 plays a leading role in NK cell activation, enhancement of T-cell proliferation and regulation of antibody production [41].”
BackgroundDepression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,863
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735
Andrade, L., Caraveo‐anduaga, J. J., Berglund, P., Bijl, R. V., Graaf, R. D., Vollebergh, W., Dragomirecka, E., Kohn, R., Keller, M., Kessler, R. C., et al. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.138 · Cited by 1,068 · cited 1×
“The risk of major depression development during a lifetime is estimated at 8–12% [6].”
BackgroundThe Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Blauvelt, A., & Chiricozzi, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8702-3 · Cited by 789 · cited 1×
“Psoriasis is a disease in which IFN-γ [42] and IL-17 [43] play an important role, hence the significance of IL-23 in the pathogenesis of this disease is not surprising.”
BackgroundUnderstanding the IL-23–IL-17 immune pathway
McKenzie, B. S., Kastelein, R. A., & Cua, D. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.10.003 · Cited by 766 · cited 1×
“It is the main cytokine connecting congenital and adaptive arms of the immune response [39], necessary to induce an early local inflammatory response [40].”
Background
Research works printed but not linked: 1
- Davami M.H. Baharlou R. Vasmehjani A.A. Ghanizadeh A. Keshtkar M. Dezhkam I. Atashzar M.R. Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder Basic Clin. Neurosci. J. 2016 7 137 142 10.15412/J.BCN.03070207 PMC4892318 27303608 · DOI · Paper page
Cited by
Neuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review
Sălcudean, A., Bodo, C.-R., Popovici, R. A., Lica, M. M., Păcurar, M., Crăciun, R.-E., Crișan, A., ENĂTESCU, V. R., Marinescu, I. P., Cîmpian, D. M., et al. (2025) · Biomolecules · doi:10.3390/biom15040502 · Cited by 201
“Increased levels of IL-18 have been observed in patients with MDD, suggesting a link between this cytokine and mood dysregulation [109].”
The Role of IL-17 Cytokines in Psoriasis
Mosca, M., Hong, J., Hadeler, E., Hakimi, M., Liao, W. J., & Bhutani, T. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s240891 · Cited by 127
The Role of IL-17 Cytokines in Psoriasis
Mosca, M., Hong, J. J., Hadeler, E. K., Hakimi, M., Liao, W. J., & Bhutani, T. (2021) · Dove Medical Press (Taylor and Francis Group) · Cited by 73
Zafiriou, E., Daponte, A., Siokas, V., Tsigalou, C., Dardiotis, E., & Bogdanos, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.699848 · Cited by 82
Inflammatory biomarkers in depression: scoping review
Paganin, W., & Signorini, S. (2024) · BJPsych Open · doi:10.1192/bjo.2024.787 · Cited by 57
“59,60,63,68,70 Variation in detection techniques and differences in the cohorts studied further reduce the ability to generalise the results.”
BackgroundInfluentialDepression in breast cancer patients: Immunopathogenesis and immunotherapy
Yu, S., Li, W., Tang, L., Fan, X., Yao, S., Zhang, X., Bi, Z., & Cheng, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215648 · Cited by 54
T helper cells in depression: central role of Th17 cells
Ghosh, R., Mitra, P., Kumar, P. V. S. N. K., Goyal, T., & Sharma, P. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1965535 · Cited by 38
“cantly reduced in the patient group [144].”
Proinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety
Keenan, E. L., & Granstein, R. D. (2025) · Acta Physiologica · doi:10.1111/apha.70019 · Cited by 43
Tabra, S. A. A., Elsayed, S. E., Amer, R. A. R., Fouda, M. H., & Abu-Zaid, M. H. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06300-1 · Cited by 34
“It was found that the level of gene expression for IL-17, IL-21, IL-23, and IL-35 was higher in patients with depression [31].”
BackgroundSoares, G. B., Mahmoud, O., Yosipovitch, G., & Mochizuki, H. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19813 · Cited by 40
“116 Of note, studies have found that patients with psoriasis treated with the anti- IL-23 medication ustekinumab reported significant improvements in mood symptoms.”
BackgroundComorbidities in Psoriatic Arthritis: A Narrative Review
Panagiotopoulos, A. G., & Fragoulis, G. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.01.006 · Cited by 40
Zhou, T., Li, M., Xiao, Z., Cai, J. Q., Zhao, W., Duan, J., Yang, Z., Guo, Z., Chen, Y., Cai, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.744251 · Cited by 36
“Some of these pathways are playing important roles in both depression and cancer, such as RAS signaling pathway (31, 37) and IL-17 signaling pathway (32, 38).”
BackgroundFusar‐Poli, L., Amerio, A., Cimpoesu, P., Filioli, P. G., Natale, A., Zappa, G., Aguglia, E., Amore, M., Serafini, G., & Aguglia, A. (2021) · Brain Sciences · doi:10.3390/brainsci11030363 · Cited by 28
“The literature extensively demonstrated that the immune and inflammatory systems may play a crucial role in determining the onset and recurrence of major depressive disorder (MDD) [31,32].”
BackgroundT cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities
Yang, J., Zhang, S., Wu, Q., Chen, P., Dai, Y., Long, J., Wu, Y., & Lin, Y. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103176 · Cited by 32
Th17-cells in depression: Implication in multiple sclerosis
Melnikov, M., & Lopatina, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010304 · Cited by 21
“They showed increase in serum IL-17 and IL-23 levels as well as IL-17 and IL23 mRNA expression in peripheral blood lymphocytes of patients with MDD (n=190) compared with the control group (n=100) (43).”
BackgroundIs the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?
Gałecka, M., Szemraj, J., Su, K., Halaris, A. E., Maes, M. H. J., Skiba, A., Gałecki, P., & Bliźniewska-Kowalska, K. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11072056 · Cited by 26
“The brain is more susceptible to the damaging effects of reactive oxygen species (ROS) due to its high metabolism, speed and low antioxidant levels, which may explain why oxidative stress is a major feature of most neurodegenerative diseases, including major depression [5,33].”
BackgroundInfluentialSelf-citationWu, S., Chen, W.-J., Chang, J. P., Guu, T., Hsin, M.-C., Huang, C., Mischoulon, D., Capuron, L., & Su, K. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13061003 · Cited by 21
“The neuroimmune hypothesis posits that inflammation may have a role in MDD as evidenced by elevated levels of markers of inflammation and oxidative stress, including interleukin-6 (IL-6), interleukin-17 (IL-17), interleukin-21 (IL-21), interleukin-35 (IL-35), tumor necrosis factor-alpha (TNF-α), 8-hydroxy-2′-deoxyguan…”
BackgroundSelf-citationZeng, Y., Li, W., Chen, X., You, Z., Mai, S., Lan, X., Ning, Y., & Zhou, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.078 · Cited by 22
Circulating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study
Bhattacharyya, U., John, J., Lam, M., Fisher, J., Sun, B. B., Baird, D. A., Burgess, S., Chen, C., & Lencz, T. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0033 · Cited by 22
“While elevated IL-23 has been associated with depression in patients with psoriatic arthritis 35 (for which IL-23 is a major causal factor) 36 , there have been mixed reports concerning the correlation between IL-23 levels in the blood of patients with idiopathic depression 37,38 .”
Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
Narbutt, J., Niedźwiedź, M., Lesiak, A., Ceryn, J., & Skibińska, M. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s350753 · Cited by 17
Dragasevic, S., Stankovic, B., Kotur, N., Sokic Milutinovic, A., Nikolic, A., Pavlovic, S., & Popovic, D. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae180 · Cited by 13
Jiang, S.-T., Wang, M., Gao, L., Zhang, Q., Tang, C., & Dong, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.195 · Cited by 15
Chronic IL-21 drives neuroinflammation and promotes lipid accumulation in microglia
Oyamada, H. A. A., Ying, Y., Agrawal, S., Liu, A., Subramanian, V. S., Bento, C. A. M., & Agrawal, A. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00510-2 · Cited by 15
Inflammatory Markers and Episodic Memory Functioning in Depressive Disorders
Wachowska, K., Szemraj, J., Śmigielski, J., & Gałecki, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030693 · Cited by 13
“The most frequently analyzed peripheral markers of inflammation in the context of depression seem to be IL-1 and IL-6, although there are many others (pro- and anti-inflammatory) also being investigation [11].”
BackgroundSelf-citationRole of interleukin 17 (IL-17) in the inflammatory hypothesis of depression
Bliźniewska-Kowalska, K. M., Halaris, A. E., Gałecki, P., & Gałecka, M. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100610 · Cited by 15
Self-citationYe, X., Ho, J. Y. S., & Chang, R. C. (2025) · Biomolecules · doi:10.3390/biom15111556 · Cited by 16
“In contrast, the mRNA expression of Foxp3 was reduced in patients with MDD, consistent with previous results suggesting decreased T regulatory cell levels in depressed patients [21,23].”
Personality Traits and Inflammation in Depressive Disorders
Wachowska, K., Gałecki, P., Szemraj, J., Śmigielski, J., & Orzechowska, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071974 · Cited by 12
Self-citationSchiweck, C., Aichholzer, M., Reif, A., & Thanarajah, S. E. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100454 · Cited by 13
Hwang, H.-G., Park, J.-W., Lee, H. J., Ko, M. Y., Ka, M., Lee, Y. K., Choi, J., In, S.-A., Lee, Y.-E., Lee, S., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2508424 · Cited by 11
“Elevated blood IL-17 levels are observed in patients with depression, 86–88 and chronic stress-induced IL-17 contributes to depression-like behaviors through neuroinflammation in mice.”
The role of interleukin-17 in neurological disorders
Park, S. E., Ferreira, A. F. F., Kwon, H., Yu, J., Diniz, L., Ulrich, H., Britto, L. R. G., & Kim, E. (2025) · Animal Cells and Systems · doi:10.1080/19768354.2025.2510994 · Cited by 9
“…190 patients diagnosed with depression, excluding those with coexisting inflammatory diseases, compared to 100 healthy individuals, elevated serum levels of IL-17 and IL-23 along with decreased levels of IL-21 and IL-35, a cytokine that coun-terbalances IL-17 (Galecka et al. 2021), were observed.”
Song, X., Zhong, Q., Zhang, R., Lai, S., Wu, Y., Yin, J., Liu, Y., Sun, J., Zhang, J., Lü, X., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119648 · Cited by 11
Stress-induced despair behavior develops independently of the Ahr-RORγt axis in CD4 + cells
Rivet-Noor, C. R., Merchak, A. R., Li, S., Beiter, R. M., Lee, S., Thomas, J. A., Fernández-Castañeda, A., Shin, J., & Gaultier, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12464-2 · Cited by 8
Xia, X., Yu, H., Li, Y., Liang, Y., Li, G., & Huang, F. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s413887 · Cited by 9
Torres-Galván, S., Flores-López, M., Romero‐Sanchiz, P., Requena-Ocaña, N., Porras-Perales, Ó., Nogueira‐Arjona, R., Mayoral, F., Araos, P. F., Serrano, A., Muga, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93075-1 · Cited by 10
Moriyama, N., Saito, M., Ono, Y., Yamashita, K., Aoi, T., & Kotani, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134309 · Cited by 7
“In fact, IL-17 levels are enhanced in patients with depression [41,43].”
Background(2023) · doi:10.3389/fpsyt.2023.1219151 · Cited by 8
“Although the etiopathogenesis of BD remains poorly understood, numerous studies have widely reported that the immune and inflammatory systems may be crucial contributors to the onset and progression of this life-threatening illness (10, 11).”
BackgroundGoleij, P., Amini, A., Sanaye, P. M., Heidari, M. M., Tabari, M. A. K., Aschner, M., Larsen, D. S., Khan, H., & Daglia, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01901-z · Cited by 14
Petrillo, A. D., Favale, A., Onali, S., Kumar, A., Abbracciavento, G., & Fantini, M. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155522 · Cited by 9
Exploring the Therapeutic Potential of Bupleurum in Medical Treatment: A Comprehensive Overview
Tian, Y., Guo, J., Jiang, X., Lu, H., Xie, J., Zhang, F., Du, Z., & Hao, E. (2025) · Pharmaceuticals · doi:10.3390/ph18091331 · Cited by 6
“Alterations in neurotransmitter levels and inflammatory markers are critical indicators of depression [95,96].”
Li, C., Li, B., Liu, H., Qu, L., & Wang, H. (2023) · Annals of Translational Medicine · doi:10.21037/atm-23-236 · Cited by 7
“By binding to surface receptors and activating related signaling pathways, IL-17 induces proinflammatory cytokines such as IL-1, IL-6, and TNF-α to bind to their corresponding receptors and induce an inflammatory response (47).”
He, J., Wang, M.-N., Chen, H.-J., Zuo, G., Li, J.-L., Yin, W., Pan, X.-G., Cheng, Y., Xia, C., Xu, J., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02354-4 · Cited by 8
“Clinical evidence also indicates that serum IL-17 levels are directly associated with HAMD scores in patients with first-episode depressive disorder [83], and IL-17 gene expression is significantly elevated in individuals with depression compared to healthy controls [84].”
Neuroimmunology and (Epi)Genetics in Depressive Disorders
Gałecki, P., Bliźniewska-Kowalska, K. M., Maes, M. H. J., & Su, K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070670 · Cited by 4
“There is strong evidence that major depression (MDD) is a neuro-immune and neurooxidative disorder with increased levels of pro-inflammatory cytokines [2,3].”
BackgroundSelf-citationBhattacharyya, U., John, J., Lam, M., Fisher, J., Sun, B. B., Baird, D. A., Chen, C., & Lencz, T. (2024) · medRxiv · doi:10.1101/2024.01.18.24301455 · Cited by 3
“While elevated IL23 has been associated with depression in patients with psoriatic arthritis 54 (for which IL23 is a major causal factor) 55 there have been mixed reports concerning the correlation between IL23 levels in the blood of patients with idiopathic depression 56,57 .”
BackgroundXu, H., Qu, K., Zhang, Z., Wang, Y., Zhao, H., Fu, J., Liu, J., Zhang, Y., Ao, X., Song, H., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158127 · Cited by 2
Comparative effects of biologics on anxiety and depression symptoms in psoriasis
Jiang, Y., Wang, Y., Huang, D., Dai, M., Zhong, X., Yao, L., Xu, S., Li, Y., Lu, J., & Shi, Y. (2025) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20702 · Cited by 1
Boller, A.-L., Freff, J., Bast, M., Schwarte, K., Dannlowski, U., Baune, B. T., Scheu, S., & Alferink, J. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1753241 · Cited by 1
Turğut, F. S., Öztürk, M., Bulut, M., Gökcüoğlu, S., Kızıl, N., & Mete, N. (2026) · Journal of Attention Disorders · doi:10.1177/10870547261428864 · Cited by 2
“In a study conducted on individuals diagnosed with major depressive disorder (MDB), a significant increase in IL-17 and IL-23 levels was observed, while a decrease in Treg activity was detected (Gałecka et al., 2021).”
Wu, J., Li, D., Mei, H., & Hu, Y. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117949 · Cited by 1
Stefanović, B., Virijević, K., Spasojević, N., Ferizović, H., Janković, M., Vasiljevic, P. J., & Dronjak, S. (2023) · Kragujevac Journal of Science · doi:10.5937/kgjsci2345149s · Cited by 2
“Many cytokines and growth hormones use the Janus activated kinase (JAK)-Signal transducer and activator of transcription proteins (STAT) signaling pathway, an intracellular protein network, to activate the expression of particular genes (GAŁECKA et al., 2021).”
BackgroundTorres-Galván, S., Flores-López, M., Ochoa, E. L. M., Requena-Ocaña, N., Araos, P. F., Herrera-Imbroda, J., Muga, R., Serrano, A., de Fonseca, F. R., Pavón, F. J., et al. (2024) · Neuropsychobiology · doi:10.1159/000536265 · Cited by 1
“It has previously been reported that the gene expression of IL-17, IL-21, IL-23, and IL-35 was signi fi cantly higher in patients with major depression, suggesting that the expression of speci fi c cytokines may contribute to the etiopathogenesis of these mood disorders [18].”
BackgroundAo, M., Yang, X., Wang, S., Li, M., Zhang, W., Ou, Q., Xu, K., & Sun, D. (2024) · Human & Experimental Toxicology · doi:10.1177/09603271241293119 · Cited by 1
RetractedStress-Induced Despair Behavior Develops Independently of the AHR-RORgt Axis in CD4+ cellsPreprint
Rivet-Noor, C. R., Merchak, A. R., Li, S., Beiter, R. M., Lee, S., Thomas, J. A., Fernández-Castañeda, A., Shin, J., & Gaultier, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1181536/v1
Innate lymphoid cells in depression: Current status and perspectives
Madeshiya, A. K., & Pillai, A. (2022) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2022.100055
“(2021) found higher IL-17 mRNA levels in peripheral blood lymphocytes of depressed subjects compared to the control group (Galecka et al., 2021).”
BackgroundCytokines as Predictors of Response to Electroconvulsive Therapy: an Update
Rajkumar, R. P. (2023) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-023-00265-4
“Animal models of stress-induced depression are associated with elevated IL-17 [77], and IL-17 is expressed at higher levels in patients with depression, including post-partum depression [78, 79].”
BackgroundLi, H., Xie, F., Cui, X., & Shen, G. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-01817-z · Cited by 1
IL-37 and Neuroimmune Mechanisms Relevant to Depressive and Anxiety Disorders: A Scoping Review
Kunikowska, J., Gałecki, P., Su, K., Bliźniewska-Kowalska, K. M., & Gałecka, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146496
“Studies of major depressive disorder have described alterations in both pro-and anti-inflammatory mediators, including IL-17, IL-21, IL-23, IL-35, and Foxp3, supporting the concept that impaired immune regulation may be involved in certain depressive phenotypes [18].”
Self-citationZhang, S., Zeng, Z.-L., Lin, X.-E., Ran, J., Wang, Q., Yang, J.-B., Wu, Y., & Lin, N.-X. (2026) · Current Medical Science · doi:10.1007/s11596-026-00226-4
Metadata
- Authors
- Gałecka, M., Bliźniewska-Kowalska, K., Orzechowska, A., Szemraj, J., Maes, M., Berk, M., Su, K.-P., & Gałecki, P.
- Affiliations
- Medical University of Lodz (PL)
- Chulalongkorn University (TH)
- Barwon Health (AU)
- China Medical University (TW)
- Corresponding author
- Gałecka, Małgorzata
- ORCID
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2021-01-23
- Volume
- 11
- Issue
- 2
- Pages
- 66
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC7911855
- OpenAlex
- W3124435187
- Cited by
- 57
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 8 · 2023: 10 · 2022: 10 · 2021: 8
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Department of Adult Psychiatry (503/5-062-02/503-51-001-19-00)
- Department of Psychotherapy (503/1-062-03/503-11-001-19-00)
- NHMRC Senior Principal Research Fellowship (1059660 and 1156072)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, inflammatory cytokines, IL-17, IL-21, IL-23, IL-35, Foxp3, gene expression, disease duration, hospitalization, autoimmune disease susceptibility, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.